Ivabradine Added to Guidelines-Based Therapy in Systolic Heart Failure Patients

Internal and Emergency Medicine - Italy
doi 10.1007/s11739-011-0594-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Addressing Major Unmet Needs in Patients With Systolic Heart Failure: The Role of Ivabradine

American Journal of Cardiovascular Drugs
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Early Short‑term Ivabradine Treatment in New‑onset Acute Systolic Heart Failure and Sinus Tachycardia Patients With Inflammatory Rheumatic Disease

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Ivabradine: Current and Future Treatment of Heart Failure

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Prevalence of Airflow Obstruction in Patients With Stable Systolic Heart Failure

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2017English

Symptom Burden of Sleep-Disordered Breathing in Systolic Heart Failure Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure ― J-Shift Study ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Insurance Status, Progression to Stage D Heart Failure, and Mortality in Stable Outpatients With Systolic Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Right Ventricular Systolic Echocardiographic Parameters in Chronic Systolic Heart Failure and Prognosis

European Heart Journal
Cardiovascular MedicineCardiology
2013English

Revascularization in Systolic Heart Failure: A Difficult Decision

Circulation
Cardiovascular MedicinePhysiologyCardiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy